-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Fulcrum Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2024.
- Fulcrum Therapeutics, Inc. Depreciation for the quarter ending December 31, 2024 was $314K, a 37.9% decline year-over-year.
- Fulcrum Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2024 was $1.59M, a 26.7% decline year-over-year.
- Fulcrum Therapeutics, Inc. annual Depreciation for 2024 was $1.59M, a 26.7% decline from 2023.
- Fulcrum Therapeutics, Inc. annual Depreciation for 2023 was $2.17M, a 10% decline from 2022.
- Fulcrum Therapeutics, Inc. annual Depreciation for 2022 was $2.41M, a 4.02% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)